chr12-80367631-G-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001378609.3(OTOGL):​c.6402G>T​(p.Leu2134Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.189 in 1,534,542 control chromosomes in the GnomAD database, including 28,595 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/17 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.18 ( 2746 hom., cov: 31)
Exomes 𝑓: 0.19 ( 25849 hom. )

Consequence

OTOGL
NM_001378609.3 missense

Scores

2
13

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 1.51

Publications

14 publications found
Variant links:
Genes affected
OTOGL (HGNC:26901): (otogelin like) The protein encoded by this gene belongs to the otogelin family. This gene is expressed in the inner ear of vertebrates with the highest level of expression seen at the embryonic stage and lowest in adult. Knockdown studies in zebrafish suggest that this gene is essential for normal inner ear function. Mutations in this gene are associated with autosomal recessive deafness. [provided by RefSeq, Dec 2012]
OTOGL Gene-Disease associations (from GenCC):
  • autosomal recessive nonsyndromic hearing loss 84B
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Laboratory for Molecular Medicine, G2P, Labcorp Genetics (formerly Invitae), PanelApp Australia
  • nonsyndromic genetic hearing loss
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • hearing loss, autosomal recessive
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0016458333).
BP6
Variant 12-80367631-G-T is Benign according to our data. Variant chr12-80367631-G-T is described in ClinVar as [Benign]. Clinvar id is 226968.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.209 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
OTOGLNM_001378609.3 linkc.6402G>T p.Leu2134Phe missense_variant Exon 54 of 59 ENST00000547103.7 NP_001365538.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
OTOGLENST00000547103.7 linkc.6402G>T p.Leu2134Phe missense_variant Exon 54 of 59 5 NM_001378609.3 ENSP00000447211.2 Q3ZCN5

Frequencies

GnomAD3 genomes
AF:
0.184
AC:
28026
AN:
151918
Hom.:
2745
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.181
Gnomad AMI
AF:
0.282
Gnomad AMR
AF:
0.216
Gnomad ASJ
AF:
0.184
Gnomad EAS
AF:
0.0430
Gnomad SAS
AF:
0.216
Gnomad FIN
AF:
0.107
Gnomad MID
AF:
0.223
Gnomad NFE
AF:
0.198
Gnomad OTH
AF:
0.190
GnomAD2 exomes
AF:
0.165
AC:
30205
AN:
182930
AF XY:
0.168
show subpopulations
Gnomad AFR exome
AF:
0.165
Gnomad AMR exome
AF:
0.185
Gnomad ASJ exome
AF:
0.179
Gnomad EAS exome
AF:
0.0364
Gnomad FIN exome
AF:
0.102
Gnomad NFE exome
AF:
0.185
Gnomad OTH exome
AF:
0.179
GnomAD4 exome
AF:
0.189
AC:
261337
AN:
1382506
Hom.:
25849
Cov.:
29
AF XY:
0.190
AC XY:
130110
AN XY:
685990
show subpopulations
African (AFR)
AF:
0.171
AC:
5241
AN:
30586
American (AMR)
AF:
0.192
AC:
6873
AN:
35810
Ashkenazi Jewish (ASJ)
AF:
0.184
AC:
4483
AN:
24346
East Asian (EAS)
AF:
0.0343
AC:
1290
AN:
37574
South Asian (SAS)
AF:
0.205
AC:
16031
AN:
78102
European-Finnish (FIN)
AF:
0.109
AC:
5625
AN:
51510
Middle Eastern (MID)
AF:
0.214
AC:
1190
AN:
5560
European-Non Finnish (NFE)
AF:
0.198
AC:
210031
AN:
1061622
Other (OTH)
AF:
0.184
AC:
10573
AN:
57396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.464
Heterozygous variant carriers
0
9182
18363
27545
36726
45908
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
7294
14588
21882
29176
36470
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.184
AC:
28028
AN:
152036
Hom.:
2746
Cov.:
31
AF XY:
0.181
AC XY:
13484
AN XY:
74334
show subpopulations
African (AFR)
AF:
0.181
AC:
7507
AN:
41472
American (AMR)
AF:
0.216
AC:
3286
AN:
15238
Ashkenazi Jewish (ASJ)
AF:
0.184
AC:
639
AN:
3464
East Asian (EAS)
AF:
0.0431
AC:
223
AN:
5176
South Asian (SAS)
AF:
0.216
AC:
1039
AN:
4820
European-Finnish (FIN)
AF:
0.107
AC:
1132
AN:
10592
Middle Eastern (MID)
AF:
0.223
AC:
65
AN:
292
European-Non Finnish (NFE)
AF:
0.198
AC:
13483
AN:
67962
Other (OTH)
AF:
0.188
AC:
397
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1172
2344
3515
4687
5859
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
298
596
894
1192
1490
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.191
Hom.:
7673
Bravo
AF:
0.192
TwinsUK
AF:
0.193
AC:
715
ALSPAC
AF:
0.199
AC:
766
ESP6500AA
AF:
0.183
AC:
807
ESP6500EA
AF:
0.192
AC:
1648
ExAC
AF:
0.160
AC:
19275
Asia WGS
AF:
0.139
AC:
482
AN:
3470

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Nov 24, 2014
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Leu2125Phe in exon 53 of OTOGL: This variant is not expected to have clinical si gnificance because it has been identified in 19.2% (1648/8584) of European Ameri can chromosomes from a broad population by the NHLBI Exome Sequencing Project (h ttp://evs.gs.washington.edu/EVS; dbSNP rs11114416). -

May 09, 2017
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
-0.65
T
BayesDel_noAF
Benign
-0.56
CADD
Benign
15
DANN
Uncertain
0.98
Eigen
Benign
-0.24
Eigen_PC
Benign
-0.22
FATHMM_MKL
Uncertain
0.80
D
LIST_S2
Benign
0.58
T;.;T
MetaRNN
Benign
0.0016
T;T;T
MetaSVM
Benign
-1.1
T
PhyloP100
1.5
PrimateAI
Benign
0.37
T
PROVEAN
Benign
-1.4
.;.;N
REVEL
Benign
0.026
Sift
Benign
0.58
.;.;T
Sift4G
Benign
0.24
.;.;T
Vest4
0.13
MPC
0.023
ClinPred
0.0016
T
GERP RS
2.7
PromoterAI
0.0028
Neutral
gMVP
0.42
Mutation Taster
=90/10
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11114416; hg19: chr12-80761411; COSMIC: COSV107327520; COSMIC: COSV107327520; API